RondinX’s New Microbiome Platform a Potential Tool for IBD Drug Discovery

RondinX’s New Microbiome Platform a Potential Tool for IBD Drug Discovery
RondinX has developed a breakthrough platform that profiles and predicts gut microbial growth dynamics by using genetic material of human gut samples. The technology may be key to understanding the interaction between changes in the gut microbiome and health, specifically the development of conditions like inflammatory bowel disease (IBD). The novel approach, established at the

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *